LHU Stock Overview
Develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
LHU passed our risk checks.
LeMaitre Vascular, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$100.00 |
| 52 Week High | US$100.00 |
| 52 Week Low | US$46.40 |
| Beta | 0.89 |
| 11 Month Change | 25.00% |
| 3 Month Change | 30.72% |
| 1 Year Change | 108.33% |
| 33 Year Change | 126.24% |
| 5 Year Change | 210.56% |
| Change since IPO | 242.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| LHU | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 4.7% | -2.5% | -1.3% |
| 1Y | 108.3% | -8.4% | 7.4% |
Return vs Industry: LHU exceeded the German Medical Equipment industry which returned -7.1% over the past year.
Return vs Market: LHU exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| LHU volatility | |
|---|---|
| LHU Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LHU has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: LHU's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 622 | George LeMaitre | www.lemaitre.com |
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries.
LeMaitre Vascular, Inc. Fundamentals Summary
| LHU fundamental statistics | |
|---|---|
| Market cap | €2.29b |
| Earnings (TTM) | €39.68m |
| Revenue (TTM) | €204.57m |
58.8x
P/E Ratio11.4x
P/S RatioIs LHU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LHU income statement (TTM) | |
|---|---|
| Revenue | US$213.03m |
| Cost of Revenue | US$67.45m |
| Gross Profit | US$145.58m |
| Other Expenses | US$104.26m |
| Earnings | US$41.32m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.84 |
| Gross Margin | 68.34% |
| Net Profit Margin | 19.40% |
| Debt/Equity Ratio | 0% |
How did LHU perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield34%
Payout RatioDoes LHU pay a reliable dividends?
See LHU dividend history and benchmarks| LeMaitre Vascular dividend dates | |
|---|---|
| Ex Dividend Date | Nov 21 2024 |
| Dividend Pay Date | Dec 05 2024 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 12 days |
Does LHU pay a reliable dividends?
See LHU dividend history and benchmarks